Original paper
THU0661 Osteoporosis screening, primary prevention, and treatment in glucocorticoid treated individuals with rheumatologic disease
Published: Jun 1, 2018
Abstract
Background
Glucocorticoids are commonly used in a wide variety of inflammatory conditions treated by rheumatologists. Bone loss from glucocorticoids is known to occur early and with relatively small doses. The American College of Rheumatology outlines that Glucocorticoid-Induced Osteoporosis (GIOP) is under screened and undertreated. The ACR guidelines suggest standard clinical care to obtain a baseline DEXA in any individual with...Paper Details
Title
THU0661 Osteoporosis screening, primary prevention, and treatment in glucocorticoid treated individuals with rheumatologic disease
Published Date
Jun 1, 2018
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History